Disposal

16 April 2004 Lawrence sells South African business Lawrence plc (Lawrence) is pleased to announce that it has sold the trading business and certain of the assets of ECO Animal Health Southern Africa (Pty) Ltd, its Pretoria based subsidiary, to the management team headed by leading veterinarian Dr Peter Oberem, who has formed a new black empowerment company, Afrivet Business Management (Pty) Ltd (Afrivet). ECO Animal Health Southern Africa (Pty) Ltd retains all its drug registrations and has agreed to their exclusive use by Afrivet. Under a new distribution and licence agreement Lawrence's UK based subsidiary, ECO Animal Health Ltd (ECO), will receive a continuing payment based on Afrivet's total sales, which should enhance the profitability of ECO. As a result of this agreement, Afrivet has paid Lawrence approximately £2 million to cover repayment of intercompany indebtedness and the purchase of tangible assets from ECO Animal Health Southern Africa (Pty) Ltd. Peter Lawrence, Chairman of Lawrence, commented: "South Africa is where ECO had its roots nearly 10 years ago and continues to be an important market for us. This transaction is particularly well timed as it benefits from the recent strength of the rand against sterling and reduces future exchange exposure to the rand. We are delighted that Peter Oberem has been able to achieve his ambition of owning the business and we are confident that it will continue to flourish under his motivating leadership. This is an excellent deal for both companies and they will continue to benefit and work closely together." Contacts: Peter Lawrence Chairman, Lawrence plc 020 8336 2900 Anthony Spiro Spiro Financial 020 8949 0428 Philip Davies Charles Stanley & Co 020 7953 2000 Lawrence plc is a leader in the development, manufacture and distribution of principally specialist chemical and pharmaceutical products for the animal health and farming markets worldwide. Our products for these growth markets incorporate natural ingredients to promote well being and sustainability. We achieve our financial goals through the careful and responsible application of science to generate value for our shareholders. Our corporate web site www.lawrenceplc.com includes our press releases together with general information about the company and its subsidiaries. Each subsidiary also has a web site, which gives further information about that business and its products.
UK 100

Latest directors dealings